Cargando…
A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792049/ https://www.ncbi.nlm.nih.gov/pubmed/36578704 http://dx.doi.org/10.4103/ijd.ijd_818_21 |
_version_ | 1784859549848567808 |
---|---|
author | Saxena, Snigdha Arora, Pooja Sardana, Kabir Muddebihal, Aishwarya Sachdeva, Soumya Ahuja, Arvind |
author_facet | Saxena, Snigdha Arora, Pooja Sardana, Kabir Muddebihal, Aishwarya Sachdeva, Soumya Ahuja, Arvind |
author_sort | Saxena, Snigdha |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9792049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-97920492022-12-27 A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale Saxena, Snigdha Arora, Pooja Sardana, Kabir Muddebihal, Aishwarya Sachdeva, Soumya Ahuja, Arvind Indian J Dermatol Correspondences Wolters Kluwer - Medknow 2022 /pmc/articles/PMC9792049/ /pubmed/36578704 http://dx.doi.org/10.4103/ijd.ijd_818_21 Text en Copyright: © 2022 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Correspondences Saxena, Snigdha Arora, Pooja Sardana, Kabir Muddebihal, Aishwarya Sachdeva, Soumya Ahuja, Arvind A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale |
title | A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale |
title_full | A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale |
title_fullStr | A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale |
title_full_unstemmed | A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale |
title_short | A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale |
title_sort | rarely employed therapeutic pearl of split-dose oral corticosteroid in severe type 2 or erythema nodosum leprosum reaction in lepromatous leprosy and its therapeutic rationale |
topic | Correspondences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792049/ https://www.ncbi.nlm.nih.gov/pubmed/36578704 http://dx.doi.org/10.4103/ijd.ijd_818_21 |
work_keys_str_mv | AT saxenasnigdha ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT arorapooja ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT sardanakabir ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT muddebihalaishwarya ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT sachdevasoumya ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT ahujaarvind ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT saxenasnigdha rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT arorapooja rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT sardanakabir rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT muddebihalaishwarya rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT sachdevasoumya rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale AT ahujaarvind rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale |